Emergent Travel Health Inc.
CAGE Code: 4VVA0
NCAGE Code: 4VVA0
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 806518598
Summary
Emergent Travel Health Inc. is an Active Commercial Supplier with the Cage Code 4VVA0 and is tracked by Dun & Bradstreet under DUNS Number 806518598..
Address
300 Professional Dr
Gaithersburg MD 20879-3428
United States
Points of Contact
No Points of Contact...
Related Information
Procurement History CAGE 4VVA0 4 Records
- NIIN
- Contract
- Date
- Quantity
- Net Price
- Std Price
- Date
- 01-658-6906
- SPE2DP18P0185
- 2017-11-08
- 25
- Subscribe
- Subscribe
- 2017-11-08
- 01-658-6906
- SPE2DP17P0873P00001
- 2017-08-16
- 10
- Subscribe
- Subscribe
- 2017-08-16
- 01-658-6906
- SPE2DP17P0849
- 2017-08-09
- 20
- Subscribe
- Subscribe
- 2017-08-09
- 01-658-6906
- SPE2DP17P0842
- 2017-08-08
- 10
- Subscribe
- Subscribe
- 2017-08-08
People who viewed this 'CAGE Code' also viewed...
Hypertek Inc Global Satcom Technology Inc Zigler Ari Mainstreet 407 Glazing Llc Jadco Engineering Inc Trevigen, Inc. Row, Klon O Inc Electra Executive Enterprise Inc Roberts Oxygen Co Blackwell Physicians, Llc Peak Technology Cellpoint Scientific, Inc. Dataport Inc Bpt Manufacturing Corporation Skytek Corp Custom Electronics Co Inc Oncor Inc Rockville Office Machines Inc. Orient Express Delivery Service Inc Biomedical Research And Development
Frequently Asked Questions (FAQ) for CAGE 4VVA0
- What is CAGE Code 4VVA0?
- 4VVA0 is the unique identifier used by NATO Organizations to reference the physical entity known as Emergent Travel Health Inc. located at 300 Professional Dr, Gaithersburg MD 20879-3428, United States.
- Who is CAGE Code 4VVA0?
- 4VVA0 refers to Emergent Travel Health Inc. located at 300 Professional Dr, Gaithersburg MD 20879-3428, United States.
- Where is CAGE Code 4VVA0 Located?
- CAGE Code 4VVA0 is located in Gaithersburg, MD, USA.
- How Many NSNs Does CAGE Code 4VVA0 Supply?
- CAGE Code 4VVA0 has been assigned as an approved source for 1 NSNs (National Stock Numbers and NATO Stock Numbers).
Contracting History for CAGE 4VVA0 Most Recent 25 Records
- 75N93022P01224
- Extended Stability Program Testing Of Two Adenoviral Hiv Vaccine Candidates
- 23 Nov 2022
- Extended Stability Program Testing Of Two Adenoviral Hiv Vaccine Candidates
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $229,878.68
- Department Of Health And Human Services (Hhs)
- 75N93022P01224
- Extended Stability Program Testing Of Two Adenoviral Hiv Vaccine Candidates
- 19 Apr 2023
- Extended Stability Program Testing Of Two Adenoviral Hiv Vaccine Candidates
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $462,515.90
- Department Of Health And Human Services (Hhs)
- 75N93022P01224
- Extended Stability Program Testing Of Two Adenoviral Hiv Vaccine Candidates
- 16 Sep 2022
- Extended Stability Program Testing Of Two Adenoviral Hiv Vaccine Candidates
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $229,878.68
- Department Of Health And Human Services (Hhs)
- 15F06721F0000585
- Paxvax Vaccines - Polio
- 18 Jan 2022
- Paxvax Vaccines - Polio
- Division 1200
- Department Of Justice (Doj)
- $0.00
- Department Of Justice (Doj)
- W81XWH16C0055
- Igf::Ot::Igf Sbir Phase Iii Mpav Clinical Study Of Prototype A - Reversal Of Mod P00002 And Corrected Application Of Clinical Study Cost Overrun
- 26 Apr 2018
- Igf::Ot::Igf Sbir Phase Iii Mpav Clinical Study Of Prototype A - Reversal Of Mod P00002 And Corrected Application Of Clinical Study Cost Overrun
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $3,446,017.21
- Department Of Defense (Dod)
- 36F79720D014E
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products 2021 Pl
- 19 Dec 2020
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products 2021 Pl
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- W81XWH16C0055
- Modern Adenovirus Vaccine Trial
- 22 Mar 2023
- Modern Adenovirus Vaccine Trial
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $3,379,885.62
- Department Of Defense (Dod)
- W81XWH16C0127
- Igf::Ot::Igf Sbir Phase Iii Paxvax Inc Mpav Production Prototype B Funded By Mantech Modification To Add Incremental Funding And To Make Administrative Corrections To The Award Document.
- 14 Dec 2017
- Igf::Ot::Igf Sbir Phase Iii Paxvax Inc Mpav Production Prototype B Funded By Mantech Modification To Add Incremental Funding And To Make Administrative Corrections To The Award Document.
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $3,375,000.00
- Department Of Defense (Dod)
- W81XWH18C0351
- Sbir Phase Iii Medical R&D Contract For Proposal #17-0001A, Titled: Modernized Production Adenovirus Vaccine (Mpav) - Incorporation Of Funds To Settle Indirect Rates For Contract Close Out
- 14 May 2021
- Sbir Phase Iii Medical R&D Contract For Proposal #17-0001A, Titled: Modernized Production Adenovirus Vaccine (Mpav) - Incorporation Of Funds To Settle Indirect Rates For Contract Close Out
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $652,166.39
- Department Of Defense (Dod)
- W81XWH18C0351
- Igf::Ot::Igf Sbir Ph Iii 17-0001A Topic A14-045 Modernized Production Adenovirus Vaccine (Mpav), Dpa Title Iii, Pre-Objective 1
- 6 Apr 2018
- Igf::Ot::Igf Sbir Ph Iii 17-0001A Topic A14-045 Modernized Production Adenovirus Vaccine (Mpav), Dpa Title Iii, Pre-Objective 1
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $443,884.67
- Department Of Defense (Dod)
- W81XWH18C0351
- Army 2014 Sbir Phase Iii Medical R&D Contract For Proposal #17-0001A, Titled: "Modernized Production Adenovirus Vaccine (Mpav)", Dpa Title Iii, Pre-Objective 1 - Change Of Name From Paxvax Inc. To Emergent Travel Health Inc.
- 27 Jan 2020
- Army 2014 Sbir Phase Iii Medical R&D Contract For Proposal #17-0001A, Titled: "Modernized Production Adenovirus Vaccine (Mpav)", Dpa Title Iii, Pre-Objective 1 - Change Of Name From Paxvax Inc. To Emergent Travel Health Inc.
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $652,166.39
- Department Of Defense (Dod)
- W81XWH16C0127
- Sbir Phase Iii. Igf::Ot::Igf
- 18 May 2017
- Sbir Phase Iii. Igf::Ot::Igf
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $3,375,000.00
- Department Of Defense (Dod)
- 36F79720D014E
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- 22 Feb 2021
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 15F06721F0000585
- Paxvax Vaccines - Polio
- 21 Jun 2021
- Paxvax Vaccines - Polio
- Division 1200
- Department Of Justice (Doj)
- $15,000.00
- Department Of Justice (Doj)
- 36F79720D014E
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals,&Hematology Related Products
- 1 Sep 2020
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals,&Hematology Related Products
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- HHSN272201000036C
- Development Of Technologies To Facilitate The Use Of And Response To Biodefense Vaccines
- 8 May 2018
- Development Of Technologies To Facilitate The Use Of And Response To Biodefense Vaccines
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $19,973,605.31
- Department Of Health And Human Services (Hhs)
- W81XWH16C0127
- Sbir Phase Iii. Igf::Ot::Igf
- 15 Feb 2017
- Sbir Phase Iii. Igf::Ot::Igf
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $3,375,000.00
- Department Of Defense (Dod)
- W81XWH16C0127
- Sbir Phase Iii Modernized Production Adenovirus Vaccine (Mpav) Add Gfp
- 31 Jul 2018
- Sbir Phase Iii Modernized Production Adenovirus Vaccine (Mpav) Add Gfp
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $3,375,000.00
- Department Of Defense (Dod)
- W81XWH16C0127
- Sbir Phase Iii. Igf::Ot::Igf
- 27 Apr 2017
- Sbir Phase Iii. Igf::Ot::Igf
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $3,375,000.00
- Department Of Defense (Dod)
- W81XWH16C0127
- Army 2014 Sbir Phase Iii Medical R&D Contract For Mpav Production Prototype B Funded By Mantech - Modification To Change Name From Paxvax Inc. To Emergent Travel Health Inc.
- 27 Jan 2020
- Army 2014 Sbir Phase Iii Medical R&D Contract For Mpav Production Prototype B Funded By Mantech - Modification To Change Name From Paxvax Inc. To Emergent Travel Health Inc.
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $3,161,941.10
- Department Of Defense (Dod)
- W81XWH16C0127
- Igf::Ot::Igf Sbir Phase Iii Modernized Production Adenovirus Vaccine (Mpav) Program - Mantech Funded - Incorporation Of Indirect Rate Cap Language
- 29 Jun 2018
- Igf::Ot::Igf Sbir Phase Iii Modernized Production Adenovirus Vaccine (Mpav) Program - Mantech Funded - Incorporation Of Indirect Rate Cap Language
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $3,375,000.00
- Department Of Defense (Dod)
- W81XWH16C0127
- Igf::Ot::Igf Sbir Phase Iii Modernized Production Of Adenovirus Vaccine (Mpav) Army Mantech Support - Stop-Work
- 19 Mar 2018
- Igf::Ot::Igf Sbir Phase Iii Modernized Production Of Adenovirus Vaccine (Mpav) Army Mantech Support - Stop-Work
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $3,375,000.00
- Department Of Defense (Dod)
- 15F06721F0000585
- Paxvax Vaccines - Polio
- 14 Jun 2021
- Paxvax Vaccines - Polio
- Division 1200
- Department Of Justice (Doj)
- $15,000.00
- Department Of Justice (Doj)
- W81XWH16C0055
- Army 2014.1 Sbir Phase Iii Medical R&D Contract For "Modern Adenovirus Vaccine Trial" - Change Of Name From Paxvax, Inc. To Emergent Travel Health, Inc.
- 3 Jan 2020
- Army 2014.1 Sbir Phase Iii Medical R&D Contract For "Modern Adenovirus Vaccine Trial" - Change Of Name From Paxvax, Inc. To Emergent Travel Health, Inc.
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $3,446,017.21
- Department Of Defense (Dod)
- W81XWH18C0351
- Sbir Phase Iii Medical R&D Contract For Proposal #17-0001A, Titled: Modernized Production Adenovirus Vaccine (Mpav) - Correct And Shorted Performance Period
- 15 Sep 2021
- Sbir Phase Iii Medical R&D Contract For Proposal #17-0001A, Titled: Modernized Production Adenovirus Vaccine (Mpav) - Correct And Shorted Performance Period
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $652,166.39
- Department Of Defense (Dod)
Supply Items Approved for CAGE 4VVA0 Page 1 of 1
- VAXCHORA
- RNCC: 5 | RNVC: 1 | DAC: 4
- NDC70460-0001-01
- RNCC: 3 | RNVC: 2 | DAC: 4